Delivery Order SPE2DB20D9331-SPE2DB25FL1R1
- Not listed
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Mirena 52 mg contraceptive systems. The award was issued under a firm fixed-price contract with an ultimate completion date of September 4, 2025. This delivery order represents a discrete procurement from DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, which is valued at approximately $500 million and valid through November...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a continuation of DMS Pharmaceutical Group's substantial role as a pharmaceutical supplier to the Department of Defense. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $2,083.12 firm fixed-price delivery order by the Defense Logistics Agency for Mirena 52 mg contraceptive systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a specific purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg Systems. The contract was awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Mirena 52 mg systems. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price structure with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $2,083.12 from the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The contract calls for the delivery of Mirena 52 mg contraceptive systems, with an ultimate completion date of August 11, 2025. This delivery order was issued without a set-aside designation and represents a single transaction under DMS...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1R1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $26,039 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on August 3, 2025, with an ultimate completion date of August 22, 2025, is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $500 million through November 2026. The delivery order carries no set-aside designation, allowing the woman-owned small business to compete directly in federal procurement based on its qualifications and pricing. DMS Pharmaceutical Group Inc., headquartered in Park Ridge, Illinois, is a woman-owned small business pharmaceutical wholesaler that has been registered in SAM.gov since 2001. The company specializes in distributing a comprehensive range of pharmaceutical products to federal agencies and Department of Defense healthcare facilities, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. Under its IDC with DLA, the company serves as a critical supplier in the federal pharmaceutical supply chain, fulfilling delivery orders for diverse medical products ranging from contraceptive devices to specialty medications and oncology treatments supporting military health facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 8/3/25 |